A study to assess the efficacy, safety & bleeding pattern of low dose (LNG) Progesterone (12 mg/24 hrs), delivered locally by a new intrauterine contraceptive system (IUS) suitable for use by women 18 to 40 years of age.
Objectives of study:
Women in need of low maintenance contraception were invited to participate in this study. Participation in this project will last for a maximum of 3 years and will involve a screening phase, baseline visit (when the LCS will be inserted), 4 visits performed every 3 months for the first year and 4 visits performed every 6 months for the subsequent 2 years.
Research status:
Content Owner: